Your browser doesn't support javascript.
loading
Predictors of COVID-19 vaccine acceptance among Nigerian medical doctors
Nri-Ezedi, C A; Okechukwu, C; Ofiaeli, O C; Nwaneli, E; Musa, S; Kida, I; Adetola, H; Ulasi, T O.
Afiliación
  • Nri-Ezedi, C A; Department of Paediatrics, Faculty of Medicine, Nnamdi Azikiwe University Awka. Anambra. NG
  • Okechukwu, C; Department of Paediatrics, Rivers State University Teaching Hospital. Rivers State. NG
  • Ofiaeli, O C; Department of Paediatrics, Faculty of Medicine, Nnamdi Azikiwe University Awka. Anambra. NG
  • Nwaneli, E; Department of Paediatrics, Faculty of Medicine, Nnamdi Azikiwe University Awka. Anambra. NG
  • Musa, S; Infectious Disease Unit, Department of Paediatrics, Ahmadu Bello University /Teaching Hospital. Shika-Zaria. NG
  • Kida, I; Infectious Disease Unit, Department of Internal Medicine, University of Maiduguri. Maiduguri. NG
  • Adetola, H; London School of Hygiene and Tropical Medicine, University of London, Keppel St, Bloomsbury. London WC1E 7HT. GB
  • Ulasi, T O; epartment of Paediatrics, Faculty of Medicine, Nnamdi Azikiwe University Awka. Anambra. NG
Article en En | AIM | ID: biblio-1362835
Biblioteca responsable: CG1.1
ABSTRACT

Background:

Since its discovery in late 2019, COVID-19 has claimed approximately three million lives worldwide, causing a significant economic burden and strain on health care delivery and services. Therefore, the COVID-19 vaccine may offer the potential to promote global recovery.

Objective:

To determine the acceptability of the COVID-19 vaccine among Nigerian doctors and the factors influencing the acceptance.

Methods:

Using a cross-sectional design, an anonymous online survey was administered to medical doctors across the six geopolitical zones in Nigeria between 13 January and 31 January 2021, using the health belief model (HBM).

Results:

Out of 830 respondents, 38.8% were willing to take the COVID-19 vaccine, 36.0% were unsure, while the remaining 26.5% refused to take the vaccine. Following adjustments, males were more likely to take the vaccine (OR = 3.357; 95% CI 2.009-5.610; p = 0.0001), whereas increasing age, higher perceived viral virulence and perceived viral infectivity were observed to be significantly associated with less likelihood of accepting the vaccine. Respondents who believed in the efficacy of ivermectin were much less likely to receive the vaccine (OR = 0.217; 95% CI 0.108-0.436; p=0.001). Concerns on vaccination safety were the main barriers to vaccine acceptability. Hypothetically addressing these concerns increased vaccine acceptance rates by approximately a third (34.6%) (p < 0.001).

Conclusion:

The proposed nationwide distribution of the COVID-19 vaccine may be met with poor vaccine acceptability among Nigerian medical practitioners. Measures specifically addressing vaccine safety concerns should be provided to allay fears and enhance the acceptability of the vaccine.
Asunto(s)
Palabras clave
Texto completo: 1 Índice: AIM Asunto principal: Médicos / Cumplimiento de la Medicación / Vacunas contra la COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Ann. Health Res. (Onabanjo Univ. Teach. Hosp.) Año: 2022 Tipo del documento: Article
Texto completo: 1 Índice: AIM Asunto principal: Médicos / Cumplimiento de la Medicación / Vacunas contra la COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Ann. Health Res. (Onabanjo Univ. Teach. Hosp.) Año: 2022 Tipo del documento: Article